Laboratorios Of Investigacion Y Desarrollo

Lima, Peru

Laboratorios Of Investigacion Y Desarrollo

Lima, Peru
SEARCH FILTERS
Time filter
Source Type

Ibrahim H.,University Paul Sabatier | Ibrahim H.,IRD Montpellier | Furiga A.,CNRS Chemical Engineering Laboratory | Najahi E.,University of Sfax | And 12 more authors.
Journal of Antibiotics | Year: 2012

An alarming increase in microbial resistance to traditional drugs and classical pharmacophores has spurred the search for new antimicrobial compounds. Indolone-N-oxides (INODs) possess a redox pharmacophore with promising, recently established, antimalarial activities. In this study, the anti-infectious properties of a series of INODs were investigated. The antibacterial activity was evaluated against five bacterial strains Gram-positive (Staphylococcus aureus, Enterococcus hirae), Gram-negative (Pseudomonas aeruginosa, Escherichia coli) and acid-fast (Mycobacterium tuberculosis). The antifungal activity was assessed using two fungal strains (Aspergillus niger, Candida albicans). The antileishmanial activity was tested against two leishmanial strains, axenically-cultured amastigote (Leishmania infantum, Leishmania amazonensis). The pharmacological activities are discussed as a function of structural and lipophilic characteristics. The Gram-positive bacterial strain E. hirae was found to be the most sensitive strain, whereas the Gram-negative E. coli was resistant to this family of compounds. One compound (64) was more potent than nalidixic acid against E. hirae, whereas another one (52) was equipotent as clotrimazole against C. albicans. INODs were microbe -cidal rather than -static. INODs showed good antitubercular activity in the low micromolar range (similar to ciprofloxacin). In addition, INOD-antiprotozoal potencies were confirmed against the leishmania parasite. INODs showed a broad spectrum of antimicrobial activity and offer a promising anti-infectious prototype worthy of being developed. © 2012 Japan Antibiotics Research Association All rights reserved.


Aponte J.C.,University of Louisville | Vaisberg A.J.,Laboratorios Of Investigacion Y Desarrollo | Castillo D.,Cayetano Heredia Peruvian University | Gonzalez G.,Cayetano Heredia Peruvian University | And 16 more authors.
Bioorganic and Medicinal Chemistry | Year: 2010

The synthesis of 2-(5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4-yl)hydrazone-derivatives (BTPs) and their in vitro evaluation against Trypanosoma cruzi trypomastigotes, Mycobacterium tuberculosis, Leishmania amazonensis axenic amastigotes, and six human cancer cell lines is described. The in vivo activity of the most active and least toxic compounds against T. cruzi and L. amazonensis was also studied. BTPs constitute a new family of drug leads with potential activity against infectious diseases. Due to their drug-like properties, this series of compounds can potentially serve as templates for future drug-optimization and drug-development efforts for use as therapeutic agents in developing countries. © 2010 Elsevier Ltd. All rights reserved.

Loading Laboratorios Of Investigacion Y Desarrollo collaborators
Loading Laboratorios Of Investigacion Y Desarrollo collaborators